[{"Assets_0_Q2_USD":91330000.0,"CommonStockSharesOutstanding_0_Q2_shares":106297792.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-30441000.0,"NetIncomeLoss_1_Q2_USD":-11498000.0,"NetIncomeLoss_2_Q2_USD":-30736000.0,"StockholdersEquity_0_Q2_USD":28210000.0,"Ticker":"EYPT","CIK":"1314102","name":"EYEPOINT PHARMACEUTICALS, INC.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]